Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-098547
Filing Date
2025-07-24
Accepted
2025-07-24 20:42:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3301
  Complete submission text file 0000950170-25-098547.txt   4882
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162878
BCLS II Investco, LP (Reporting) CIK: 0001818893 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Subject) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40671 | Film No.: 251148275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)